Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1126
Graco
GGG
$12.8B
| $11.8M | 0.01% |
246,500
+171,400
| +228% | +$8.08M |
2020 Q1
1 quarter
|
|
1127
Wipro
WIT
$16.8B
| $11.8M | 0.01% |
7,134,386
+862,962
| +14% | +$1.35M |
2014 Q2
24 quarters
|
|
1128
Qiagen
QGEN
$9.34B
| $11.8M | 0.01% |
+259,807
| New | +$11.6M |
2020 Q2
0 quarters
|
|
|
MYOV
1129
DELISTED
Myovant Sciences Ltd.
MYOV
| $11.7M | 0.01% |
569,266
+540,566
| +1,884% | +$7.35M |
2020 Q1
1 quarter
|
|
|
CHS
1130
DELISTED
Chicos FAS, Inc.
CHS
| $11.7M | 0.01% |
8,503,100
-647,592
| -7% | -$880K |
2017 Q3
11 quarters
|
|
1131
Arrow Financial
AROW
$687M
| $11.7M | 0.01% |
443,964
-27,350
| -6% | -$669K |
2013 Q2
28 quarters
|
|
1132
Tenet Healthcare
THC
$21.7B
| $11.7M | 0.01% |
645,975
+106,500
| +20% | +$2.1M |
2019 Q3
3 quarters
|
|
1133
Ardelyx
ARDX
$831M
| $11.7M | 0.01% |
1,689,334
-298,000
| -15% | -$2.07M |
2017 Q3
11 quarters
|
|
1134
DELISTED
Dime Community Bancshares
DCOM
| $11.6M | 0.01% |
846,172
-202,400
| -19% | -$2.93M |
2013 Q3
27 quarters
|
|
|
PTNR
1135
DELISTED
Partner Communications
PTNR
| $11.6M | 0.01% |
2,686,551
+901
| +0% | +$3.66K |
2013 Q2
28 quarters
|
|
1136
Hawaiian Electric Industries
HE
$1.49B
| $11.6M | 0.01% |
321,303
+109,300
| +52% | +$4.24M |
2014 Q4
22 quarters
|
|
1137
Mohawk Industries
MHK
$7.98B
| $11.6M | 0.01% |
+113,638
| New | +$10M |
2020 Q2
0 quarters
|
|
1138
Amphastar Pharmaceuticals
AMPH
$1.13B
| $11.5M | 0.01% |
511,300
-227,300
| -31% | -$4.16M |
2017 Q4
10 quarters
|
|
1139
Popular Inc
BPOP
$10.1B
| $11.5M | 0.01% |
+308,375
| New | +$11.5M |
2020 Q2
0 quarters
|
|
1140
Schwab Short-Term US Treasury ETF
SCHO
$15.4B
| $11.5M | 0.01% |
443,774
+150,574
| +51% | +$3.89M |
2019 Q1
5 quarters
|
|
1141
Amkor Technology
AMKR
$12B
| $11.4M | 0.01% |
928,700
-841,000
| -48% | -$8.68M |
2013 Q2
28 quarters
|
|
1142
IDT Corp
IDT
$2.04B
| $11.4M | 0.01% |
1,745,597
-47,600
| -3% | -$281K |
2013 Q2
28 quarters
|
|
|
SCPL
1143
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $11.4M | 0.01% |
767,600
+706,600
| +1,158% | +$8.67M |
2020 Q1
1 quarter
|
|
1144
NVE Corp
NVEC
$536M
| $11.4M | 0.01% |
184,017
+4,417
| +2% | +$252K |
2013 Q2
28 quarters
|
|
1145
PAMT Corp
PAMT
$272M
| $11.4M | 0.01% |
1,478,296
-34,400
| -2% | -$287K |
2013 Q2
28 quarters
|
|
1146
Pentair
PNR
$8.38B
| $11.4M | 0.01% |
298,837
+228,173
| +323% | +$8.03M |
2020 Q1
1 quarter
|
|
1147
Chatham Lodging
CLDT
$641M
| $11.3M | 0.01% |
1,842,276
-261,000
| -12% | -$1.75M |
2013 Q2
28 quarters
|
|
|
PFNX
1148
DELISTED
Pfenex Inc.
PFNX
| $11.3M | 0.01% |
1,349,705
-200,200
| -13% | -$1.5M |
2015 Q1
21 quarters
|
|
1149
Silgan Holdings
SLGN
$3.75B
| $11.3M | 0.01% |
347,680
+21,900
| +7% | +$713K |
2016 Q4
14 quarters
|
|
1150
Peabody Energy
BTU
$3.1B
| $11.3M | 0.01% |
3,906,853
+301,300
| +8% | +$995K |
2017 Q3
11 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.